糖类抗原-125:对心房颤动的预测价值

李梦; 刘恋; 吴延庆

doi:10.13201/j.issn.1001-1439.2019.03.003

糖类抗原-125:对心房颤动的预测价值

- 南昌大学第二附属医院心血管内科(南昌, 330000)
基金项目:
国家自然科学基金（No：81660062）

详细信息

通讯作者: 吴延庆,E-mail:wuyanqing01@sina.com

中图分类号: R541.7

收稿日期: 2018-11-30

Carbohydrate antigen-125: the predictive value of atrial fibrillation

- Department of Cardiovascular Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, 330000, China

More Information

Corresponding author: WU Yanqing, E-mail: wuyanqing01@sina.com

Received Date: 30 November 2018

摘要

摘要: 糖类抗原-125（CA-125）传统上被认为是肿瘤标记物，多见于上皮性卵巢肿瘤（浆液性肿瘤）患者血清中。近年来的研究表明，CA-125与心房颤动（房颤）关系密切，本文将结合最新的研究进展阐述CA-125水平与房颤风险之间的关系，旨在为临床诊疗及预测房颤风险提供依据。
- 糖类抗原-125 /
- 心房颤动 /
- 预测
Abstract: Carbohydrate antigen-125 (CA-125) is traditionally considered as a tumor marker, which is commonly found in the serum of patients with epithelial ovarian tumors (serous tumors).Recent studies have shown that CA-125 is closely related to atrial fibrillation (AF).This article will elaborate the latest research progress on the relationship between CA-125 level and the risk of atrial fibrillation, which aims to provide a basis for clinical diagnosis, treatment and prediction of atrial fibrillation.
- carbohydrate antigen-125 /
- atrial fibrillation /
- predict

HTML全文

参考文献(19)

[1]	Sekiguchi H, Shimamoto K, Takano M, et al.Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women[J].Heart, 2017, 103(17):1368-1373.
[2]	陈伟伟, 高润霖, 刘力生, 等.《中国心血管病报告2017》概要[J].中国循环杂志, 2018, 33(1):1-8.
[3]	Henderson JT, Webber EM, Sawaya GF.Screening for Ovarian Cancer:Updated Evidence Report and Systematic Review for the US Preventive Services Task Force[J].JAMA, 2018, 319(6):595-606.
[4]	Separham A, Abbasnezhad M, Shahnazarli G, et al.Role of plasma levels of CA-125 in predicting outcome of primary PCI after acute myocardial infarction in male patients[J].J Cardiovasc Thorac Res, 2018, 10(2):109-112.
[5]	Zhang M, Li YL, Yang X, et al.Clinical significance of serum carbohydrate antigen 125 in acute exacerbation of chronic obstructive pulmonary disease[J].Nan Fang Yi Ke Da Xue Xue Bao, 2016, 36(10):1386-1389.
[6]	Namikawa T, Kawanishi Y, Fujisawa K, et al.Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer[J].Surg Today, 2018, 48(4):388-394.
[7]	Huang F, Chen J, Liu Y, et al.New mechanism of elevated CA125 in heart failure:the mechanical stress and inflammatory stimuli initiate CA125 synthesis[J].Med Hypotheses, 2012, 79(3):381-383.
[8]	Kaya H, Zorlu A, Yucel H, et al.Higher cancer antigen 125 level is associated with the presence of permanent atrial fibrillation in systolic heart failure patients[J].Acta Cardiol, 2016, 71(1):61-66.
[9]	Yucel H, Kaya H, Zorlu A, et al.Cancer antigen 125 levels and increased risk of new-onset atrial fibrillation[J].Herz, 2015, 40(Suppl 2):119-124.
[10]	De Gennaro L, Brunetti ND, Montrone D, et al.Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation[J].Eur J Clin Invest, 2012, 42(4):371-375.
[11]	Kotecha D, Chudasama R, Lane DA, et al.Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction:A systematic review and meta-analysis of death and adverse outcomes[J].Int J Cardiol, 2016, 203:660-666.
[12]	Yilmaz MB, Zorlu A, Tandogan I.Plasma CA-125 level is related to both sides of the heart:a retrospective analysis[J].Int J Cardiol, 2011, 149(1):80-82.
[13]	段雯, 罗玉梅, 潘莹, 等.房颤与N-末端脑钠肽前体、血清糖类抗原125的关系[J].热带医学杂志, 2015, 15(4):533-535.
[14]	Schnabel RB, Larson MG, Yamamoto JF, et al.Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community[J].Circulation, 2010, 121(2):200-207.
[15]	Vizzardi E, D'Aloia A, Curnis A, et al.Carbohydrate antigen 125:a new biomarker in heart failure[J].Cardiol Rev, 2013, 21(1):23-26.
[16]	Duman D, Palit F, Simsek E, et al.Serum carbohydrate antigen 125 levels in advanced heart failure:relation to B-type natriuretic peptide and left atrial volume[J].Eur J Heart Fail, 2008, 10(6):556-559.
[17]	D'Aloia A, Faggiano P, Aurigemma G, et al.Serum levels of carbohydrate antigen 125 in patients with chronic heart failure:relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis[J].J Am Coll Cardiol, 2003, 41(10):1805-1811.
[18]	Vizzardi E, Nodari S, D'Aloia A, et al.CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure[J].Echocardiography, 2008, 25(9):955-960.
[19]	Yilmaz MB, Zorlu A, Tandogan I.Plasma CA-125 level is related to both sides of the heart:a retrospective analysis[J].Int J Cardiol, 2011, 149(1):80-82.